860797-25-7

Upstream product

• 180323-49-3 (1S,3R)-3-amino-cyclopentanecarboxylic acid methyl ester hydrochloride 
• 130931-83-8 (1S,4R)-2-azabicyclo[2,2,1]hept-5-en-3-one 
• 4088-84-0 2-fluoro-5-trifluoromethyl-benzonitrile 
• 860797-39-3 C₂₀H₂₂F₆N₂O₃ 
• 860797-40-6 C₁₈H₂₃F₃N₂O₂ 
• 693245-59-9 C₂₃H₂₇NO₂ 
• 624734-28-7 C₂₀H₂₁NO₂ 
• 624734-30-1 (1S,3R)-3-((tert-butoxycarbonyl)amino)-1-isopropylcyclopentane-1-carboxylic acid 
• 624734-29-8 (1S,3R)-methyl-3-[(tert-butoxycarbonyl)amino]-1-isopropylcyclopentanecarboxylate 
• 693248-13-4 (2-(tert-butoxy)-5-(trifluoromethyl)phenyl)methanamine 
• 693248-12-3 2-tert-butoxy-5-trifluoromethylbenzonitrile 

Downstream Products

• 860797-26-8 C₂₈H₃₃F₃N₂O₅ 

Relevant academic research and scientific papers

ALKYLAMINO, ARYLAMINO, AND SULFONAMIDO CYCLOPENTYL AMIDE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY

Compounds of the formula (I) which are modulators of chemokine receptor activity useful in the prevention or treatment of certain inflammatory and immunoregulatory disorders and diseases, allergic diseases, atopic conditions including allergic rhinitis, dermatitis, conjunctivitis, and asthma, as well as autoimmune pathologies such as rheumatoid arthritis and atherosclerosis, and pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which chemokine receptors are involved.